Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Assets Average (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Assets Average for 6 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 192.67% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 192.67% year-over-year, with the annual reading at $1.3 million for FY2025, 166.86% up from the prior year.
  • Assets Average for Q4 2025 was $1.9 million at BioScience Health Innovations, down from $2.1 million in the prior quarter.
  • The five-year high for Assets Average was $2.1 million in Q3 2025, with the low at $1378.5 in Q2 2021.
  • Average Assets Average over 5 years is $428257.6, with a median of $81302.2 recorded in 2022.
  • The sharpest move saw Assets Average tumbled 91.05% in 2021, then soared 3366.2% in 2022.
  • Over 5 years, Assets Average stood at $51224.0 in 2021, then crashed by 56.47% to $22298.0 in 2022, then soared by 322.43% to $94194.5 in 2023, then surged by 584.55% to $644809.0 in 2024, then skyrocketed by 192.67% to $1.9 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.9 million, $2.1 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.